| MRI breast screening in high-risk women: cancer detection and survival analysis DG Evans, N Kesavan, Y Lim, S Gadde, E Hurley, NJ Massat, AJ Maxwell, ... Breast cancer research and treatment 145 (3), 663-672, 2014 | 183 | 2014 |
| Safety and feasibility of breast lesion localization using magnetic seeds (Magseed): a multi-centre, open-label cohort study JR Harvey, Y Lim, J Murphy, M Howe, J Morris, A Goyal, AJ Maxwell Breast cancer research and treatment 169, 531-536, 2018 | 146 | 2018 |
| The Royal College of Radiologists Breast Group breast imaging classification AJ Maxwell, NT Ridley, G Rubin, MG Wallis, FJ Gilbert, MJ Michell, ... Clinical radiology 64 (6), 624-627, 2009 | 123 | 2009 |
| Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ AJ Maxwell, MK Clements, MB Hilton, DJ Dodwell, A Evans, MO Kearins, ... European Journal of Surgical Oncology, 2018 | 103 | 2018 |
| Clinical Effectiveness and Cost-Effectiveness of Different Surveillance Mammography Regimens After the Treatment for Primary Breast Cancer: Systematic Reviews, Registry … C Robertson, SK Arcot Ragupathy, C Boachie, JM Dixon, C Fraser, ... NIHR Evaluation, Trials and Studies Coordinating Centre (UK), 2011 | 103 | 2011 |
| Ultrasound-guided vacuum-assisted excision of breast papillomas: review of 6-years experience AJ Maxwell Clinical radiology 64 (8), 801-806, 2009 | 94 | 2009 |
| Is the future magnetic? Magseed localisation for non palpable breast cancer. A multi-centre non randomised control study K Zacharioudakis, S Down, Z Bholah, S Lee, T Khan, AJ Maxwell, ... European Journal of Surgical Oncology 45 (11), 2016-2021, 2019 | 91 | 2019 |
| What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC … DP French, S Astley, AR Brentnall, J Cuzick, R Dobrashian, SW Duffy, ... BMC cancer 20, 1-14, 2020 | 89 | 2020 |
| Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants DGR Evans, EF Harkness, AR Brentnall, EM van Veen, SM Astley, ... Breast cancer research and treatment 176, 141-148, 2019 | 78 | 2019 |
| Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project AM Thompson, K Clements, S Cheung, SE Pinder, G Lawrence, E Sawyer, ... European Journal of Cancer 101, 210-219, 2018 | 74 | 2018 |
| How do women experience a false-positive test result from breast screening? A systematic review and thematic synthesis of qualitative studies H Long, JM Brooks, M Harvie, A Maxwell, DP French British journal of cancer 121 (4), 351-358, 2019 | 60 | 2019 |
| Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all cause mortality DG Evans, EF Harkness, A Howell, M Wilson, E Hurley, MM Holmen, ... Hereditary Cancer in Clinical Practice 14 (1), 1, 2016 | 60 | 2016 |
| Sonographic appearance of epidermoid cyst of the testis AJ Maxwell, H Mamtora J Clin Ultrasound 18 (3), 188-190, 1990 | 59 | 1990 |
| Extending the age range for breast screening in England: pilot study to assess the feasibility and acceptability of randomization K Moser, S Sellars, M Wheaton, J Cooke, A Duncan, A Maxwell, M Michell, ... Journal of medical screening 18 (2), 96-102, 2011 | 56 | 2011 |
| Primary and metastatic lobular carcinoma of the breast MDJ Harake, AJ Maxwell, SA Sukumar Clinical radiology 56 (8), 621-630, 2001 | 56 | 2001 |
| Opportunities and priorities for breast surgical research RI Cutress, SA McIntosh, S Potter, A Goyal, CC Kirwan, J Harvey, ... The Lancet Oncology 19 (10), e521-e533, 2018 | 52 | 2018 |
| Axillary surgery following neoadjuvant chemotherapy–multidisciplinary guidance from the association of breast surgery, faculty of clinical oncology of the royal college of … A Gandhi, C Coles, A Makris, E Provenzano, A Goyal, AJ Maxwell, ... Clinical Oncology 31 (9), 664-668, 2019 | 47 | 2019 |
| Breast cancer risk stratification in women of screening age: incremental effects of adding mammographic density, polygenic risk, and a gene panel DGR Evans, EM van Veen, EF Harkness, AR Brentnall, SM Astley, ... Genetics in Medicine 24 (7), 1485-1494, 2022 | 43 | 2022 |
| Lesion size is a major determinant of the mammographic features of ductal carcinoma in situ: findings from the Sloane project A Evans, K Clements, A Maxwell, H Bishop, A Hanby, G Lawrence, ... Clinical radiology 65 (3), 181-184, 2010 | 41 | 2010 |
| Lesion size is a major determinant of the mammographic features of ductal carcinoma in situ: findings from the Sloane Project. A Evans, K Clements, A Maxwell, H Bishop, A Hanby, G Lawrence, ... Breast cancer research: BCR 10 (Suppl 3), P14-P14, 2007 | 41 | 2007 |
Anthony Howell, Howell A, Howell TProfessor of Medical Oncology, Manchester UniversityCorreu electrònic verificat a picr.man.ac.uk
